Current Challenges in Oncology Pharmacy



Eric Dallara, RPh, pharmacist for the New England Cancer Specialists explains the current challenges in the industry, especially regarding payment plans and payment reform during the National Community Oncology Dispensing Association, Inc. in Denver, Colorado. 

Transcript
I mean, currently, obviously, it’s just going past the first the first fill, or even the first fill period, where we’ve been pretty much shut out from a lot of these commercial plans, so that’s been very frustrating. Because patients won’t always understand that, “I come here for my treatment but you can’t provide me with the medication I need for my cancer,” and that’s kind of a hard thing sometimes. So that’s definitely one thing. Payment reform is another thing. We’re part of the OCM project too, so getting some insight into that, and then all the different things that they’re doing in Congress currently right now. So those are some challenges that I see.


Related Articles

Top news of the day from across the health care landscape.
Colon cancer may spread to other parts of the body before original tumors are clinically detectable.
Top news of the day from across the health care landscape.
Company Profile >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2019
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.
 

$vacMongoViewPlus$